|
|
||||||||
AJP - Lung Cellular and Molecular Physiology, Vol 262, Issue 2 208-L213, Copyright © 1992 by American Physiological Society
ARTICLES |
S. Shimura, H. Ishihara, M. Satoh, T. Masuda, N. Nagaki, H. Sasaki and T. Takishima
First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
We examined the effects of endothelin on both the trichloroacetic acid precipitable 3H-labeled glycoconjugate release and intracellular Ca2+ concentration ([Ca2+]i]) measured by the usage of fura-2 in submucosal glands isolated from feline trachea. Endothelin-1 produced a significant increase in glycoconjugate release from the isolated glands in a dose-dependent fashion, reaching a response of 161% of the control at 10(-6) M. Atropine, propranolol, phentolamine, or indomethacin did not produce any significant alterations in the ET-1-evoked glycoconjugate secretion from the isolated glands. In contrast, in tracheal explants which contained epithelium, ET-1 produced a significant reduction in the glycoconjugate secretion in a dose-dependent fashion, reaching a response of 59% of the control at 10(-6) M. In the presence of cultured epithelial cells, ET-1 also produced a significant reduction in the glycoconjugate secretion from isolated glands. In isolated glands, ET-1 produced a sustained increase in the [Ca2+]i which was abolished by the removal of Ca2+ from the medium or by the presence of cultured epithelial cells. Pretreatment with indomethacin failed to alter the epithelial inhibitory action evoked by ET-1 in both the glycoconjugate secretion and the [Ca2+]i in isolated glands. ET-2 and ET-3 failed to produce significant alterations in the glycoconjugate secretion or [Ca2+]i. These findings indicate 1) that ET-1 induces mucus glycoprotein secretion via a Ca2+ influx and 2) that it possibly augments the an epithelial action inhibitory to the mucus glycoprotein secretion from airway submucosal glands.
This article has been cited by other articles:
![]() |
P. J. Henry, T. S. Mann, A. C. D'Aprile, G. J. Self, and R. G. Goldie An endothelin receptor antagonist, SB-217242, inhibits airway hyperresponsiveness in allergic mice Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1072 - L1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Finsnes, T. Lyberg, G. Christensen, and O. H. Skjonsberg Effect of endothelin antagonism on the production of cytokines in eosinophilic airway inflammation Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L659 - L665. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salmon, Y.-C. Liu, J. C. W. Mak, J. Rousell, T.-J. Huang, T. Hisada, P. L. Nicklin, and K. Fan Chung Contribution of Upregulated Airway Endothelin-1 Expression to Airway Smooth Muscle and Epithelial Cell DNA Synthesis after Repeated Allergen Exposure of Sensitized Brown-Norway Rats Am. J. Respir. Cell Mol. Biol., November 1, 2000; 23(5): 618 - 625. [Abstract] [Full Text] |
||||
![]() |
P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. FINSNES, G. CHRISTENSEN, T. LYBERG, O. M. SEJERSTED, and O. H. SKJONSBERG Increased Synthesis and Release of Endothelin-1 during the Initial Phase of Airway Inflammation Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1600 - 1606. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |